Why is this important? Under normal circumstances, donor blood is the best replacement for blood. HOWEVER:  Natural epidemics (e.g. HIV, Ebola etc) or man-made epidemics (terrorism, war, etc) can result in contaminated donor blood or disqualified disease contact donors. (unlike rbc, blood substitutes can be sterilized to remove infective agents)  Heart attack and stroke are usually caused by obstruction of arterial blood vessels. Unlike rbc particles, blood substitute is a solution and in animal studies it can more easily perfuse through obstructed vessels to reach the heart and brain.  Severe blood loss from accidents, disasters or war may require urgent blood transfusion that cannot wait for transportation to the hospital for blood group testing. (unlike red blood cells (rbc), blood substitutes do not have blood groups and can be given on the spot)  Red blood cells have to be stored in refrigeration for up to 42 days thus difficult to transport and store in disaster and frontline. (Blood substitutes can be stored at room temperature for more than 1 year, compared to rbc of 1 day at room temperature)  In very severe hemorrhagic shock there is usually a safety window of 60 min for blood replacement, beyond which there could be problems related to irreversible shock. Animal study shows that one type of blood substitutes with enhanced rbc enzymes may be able to prolong the time..
(2) Oxygen carriers + removal of oxygen radicals: This can be a soluble complex of Polyhemoglobin containing antioxidant enzymes to remove oxygen radicals (PolyHb-SOD-CAT) (D'Agnillo & Chang Nature Biotech 1998). It can prevent ischemia-reperfusion injury in an hemorrhagic shock-cerebral ischemia (Powanda & Chang 2002 ) (with support from CIHR and FRSQ). Conjugated hemoglobin containing synthetic antioxidants (PNPH) (Ma & Hsia 2013 ) is another example. Others included those of Simoni et al (1997) , Rousselot et al (2006) , Jia & Alayash (2013) .
(3) All 3 rbc functions (Carries Oxygen + removes oxygen radicals + carries carbon dioxide). Other conditions as in sustained severe hemorrhagic shock may require all three rbc functions. With support from the CIHR/Canadian Blood Service, we have designed a novel soluble nanobiotechnological complex (PolyHb-SOD-CAT-CA). It not only has all 3 rbc functions, but it can have enhancement of all 3 rbc functions by increasing the concentrations of rbc enzymes in the complex. These rbc enzymes can be extracted from rbc inexpensively (Guo, Gynn & Chang 2015) . This complex has no blood groups. The lyophilized preparation can be heat pasteurized at 68F for 2 h. This can be important if there is a need to inactivate H.I.V. virus, Ebola virus, and other infective organisms. Unlike about 1 day for rbc at room temperature, this lyophilized preparation can be stored in room temperature for 320 days. Our result in a 90 minutes hemorrhagic shock animal model with 2/3 blood volume loss shows that it is superior to whole blood in the following ways: lowering of elevated intracellular pCO 2 , recovery of ST elevation, protonin levels, lowering of elevated lactate, histology of the heart and intestine. International progress up to now shows that it is possible to tailor-make blood substitutes ranging from simple to complex. It is urgent to have these ready without again waiting until it is too late. We need to analyze the specific indications for 1,2 and 3 above. If a condition only needs oxygen then there is no need to use a more complex one. On the other hand, it would be folly not to use a more complex one if indicated. We also need to intensify research on the many important ongoing research around the world (references for these are in the next page). Examples include: develop other novel approaches including novel crosslinkers; new sources of material from porcine, bovine, human cord rbc, recombinant, Arenicola marina; basic research on nitric oxide, oxidative stress, haptoglobin, rate of oxygen supply; safety and efficacy analysis and many other areas. The 2015 XV Int Symposium on Blood Substitute at Lund University (Professor Lief Bulow), Lund, Sweden http://isbs2015.lu.se to be followed by the 2017 XVI at McGill University (Professor TMS Chang), Montreal Canada www.medicine.mcgill.ca/artcell , will be excellent opportunities for international exchanges.
